Michael A. Kutcher, MD, FACC, FSCAI

Highlights of the Scottsdale Interventional Forum 2014, How-to Symposiums: Advances in Chronic Total Occlusion Therapy

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Habib Samady , MD;

Justin E. Davies , MBBS, MRCP, PhD;

Peter Ver Lee , MD;

John Bittl , MD;

Samuel M. Butman , MD;

Lloyd W. Klein , MD;

My cardiology fellow said we should now stent the RCA since we were already here and the patient was quite stable. I demurred and said we will be back in a couple weeks unless the patient develops angina. The RCA could be treated after...

My cardiology fellow said we...

01/07/2014

Cath Lab Digest

02/01/2015

Boomer to Zoomer – Transforming to the Post-Pandemic World

Ashish Pershad , MD;

Mohamad Lazkani , MD;

David G. Rizik , MD, FACC, FSCAI;

Moneer Eddin , MD;

William L. Lombardi , MD;

The tenth annual Scottsdale Interventional Forum (SIF), which took place in Scottsdale, Arizona from March 5-8, 2014, brought together some of the leading experts in CTO-PCI. Topics discussed included review of the diagnostic coronary...

The tenth annual Scottsdale...

02/01/2015

Journal of Invasive Cardiology

Clinical Editor's Corner

07/06/2020

Barry F. Uretsky , MD;

Stephen R. Ramee , MD;

Peter C. Block , MD;

Frederic S. Resnic , MD, MSc;

Lloyd W. Klein , MD;

E. Magnus Ohman , MD;

Samuel M. Butman , MD;

Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan

Jeffrey Marshall ;

Gary S. Mintz , MD;

Jonathan M. Tobis , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Chet Rihal ;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Carl L. Tommaso , MD;

Michael J. Lim , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

Christopher J. White , DO, MD;

Kirk N. Garratt , MD, MSc;

Jim Blankenship , MD;

Like many of my contemporaries, I am a boomer (aka baby boomer), a member of the post World War II generation. I grew up in the 1950-60s, graduated college in the Vietnam War era (1960-70s), and had a millennial-generation (1980-90s)...

Like many of my contemporaries,...

07/06/2020

Cath Lab Digest

08/01/2008

Vasoreactivity Testing and Chest Pain Guidelines: Is the IIa Recommendation Warranted? INOCA Part II

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

Clinical Editor's Corner

09/05/2022

Lloyd W. Klein , MD;

Amir Lerman , MD;

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

Augusto D. Pichard , MD, FACC, FSCAI;

Samuel M. Butman , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Colin Berry , MBChB, BSc, PhD, MRCP;

Bernard DeBruyne ;

Gregory J. Dehmer , MD;

Spencer B. King III, MD;

Kreton Mavromatis , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David J. Moliterno , MD;

Srihari S. Naidu , MD;

Jonathan M. Tobis , MD;

Peter C. Block , MD;

Timothy D. Henry , MD;

Olga Toleva ;

INOCA and MINOCA (myocardial infarction with normal coronary arteries) are now widely known and gathering attention regarding their diagnosis and treatment. Many labs now have sensor guidewires and software to make this possible. Specialized...

INOCA and MINOCA (myocardial...

09/05/2022

Cath Lab Digest

08/01/2008

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

PCI with and without Abciximab after Upstream Eptifibatide Use: Outcomes in High-Risk Patients

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Talal T. Baki , MD;

William C. Little , MD;

Vascular Complications in Women after Catheterization and Percutaneous Coronary Intervention 1998‚Äì2005

David C. Sane , MD;

Mark A. Grabarczyk , MD;

Jason E. Goodin , BA;

Sidney Statonk , MD;

Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...

Several clinical trials have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Propensity Score Analysis of Vascular Complications after
Diagnostic Cardiac Catheterization and Percutaneous Coronary Interven

Women have been shown historically to have a greater risk of complications than men following invasive procedures.1–5 The increased incidence of complications in women appears to occur independently of other factors known to influence the...

Women have been shown...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephr

Renato M. Santos , MD;

Cardiac catheterization and PCI are usually performed by percutaneous access using the femoral artery. Following completion of the procedure, hemostasis is traditionally performed by manual compression, followed by 6 hours of bed rest....

Cardiac catheterization and PCI...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Jason Call , MD;

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;